| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/04/1992 | CA2092801A1 Method for treating inflammation using anti-idiotypic antibodies |
| 04/03/1992 | CA2052501A1 Monoclonal antibodies directed against complexes formed by thrombin and thrombin inhibitors |
| 04/02/1992 | WO1992006218A1 A novel onco-fetal gene, gene product and uses therefor |
| 04/02/1992 | WO1992006198A1 Salmonella polynucleotide sequence |
| 04/02/1992 | WO1992006197A1 Method of testing for salmonella |
| 04/02/1992 | WO1992005274A1 Framework mutated antibodies and their preparation |
| 04/02/1992 | WO1992005271A1 Process for the preparation of c-terminally amidated peptides |
| 04/02/1992 | WO1992005256A1 Natural killer stimulatory factor |
| 04/02/1992 | WO1992005254A1 Novel neurothrophic factor |
| 04/02/1992 | WO1992005244A1 Expression of g protein coupled receptors in yeast |
| 04/02/1992 | WO1992005239A1 Detergent containing protease and inhibitor and novel inhibitors for use therein |
| 04/02/1992 | WO1992005197A1 Purification of cytokeratin fragments |
| 04/02/1992 | WO1992005196A1 Aids therapy and vaccine |
| 04/02/1992 | WO1992005193A1 Plasmodium liver stage antigens |
| 04/02/1992 | WO1992005184A1 A non-mitogenic competitive hgf antagonist |
| 04/02/1992 | WO1992004914A1 Design of bioactive peptides based on immunoglobulin structure |
| 04/02/1992 | WO1991018047A3 Mammalian expression of the bmp-2 family |
| 04/02/1992 | WO1991009872A3 Hiv-1 env fragment fusion protein |
| 04/02/1992 | CA2092920A1 Aprotinin analogues |
| 04/02/1992 | CA2092916A1 Onco-fetal gene, gene product and uses therefor |
| 04/02/1992 | CA2091984A1 Salmonella polynucleotide sequence |
| 04/02/1992 | CA2091982A1 Method of testing for salmonella |
| 04/02/1992 | CA2091258A1 Design of bioactive peptides based on immunoglobulin structure |
| 04/02/1992 | CA2069507A1 Aids therapy and vaccine |
| 04/01/1992 | EP0478366A2 Recombinant hybrid immunoglobulin molecules and method of use |
| 04/01/1992 | EP0478333A1 Gene selective expression with vectors containing protector and suppressor viral sequences |
| 04/01/1992 | EP0478272A2 Gp98 cell adhesion molecule and integrin complex containing it |
| 04/01/1992 | EP0478017A1 Monoclonal antibody with specificity for human myosin light chains |
| 04/01/1992 | EP0477739A2 Glycosyl-Phosphatidylinositol-Specific Phospholipase D |
| 04/01/1992 | EP0477345A1 Respiratory burst suppression factor |
| 04/01/1992 | EP0477290A1 Methods, compositions and devices for growing cells. |
| 04/01/1992 | EP0477269A1 Pharmaceutical compositions and methods of treatment using alzheimer's amyloid polypeptides |
| 04/01/1992 | EP0477226A1 Contraceptive vaccine based on cloned zona pellucida gene |
| 04/01/1992 | CN1059935A Regulatory nucleotide sequence of initiation of transcription |
| 03/31/1992 | US5101018 Somatotropin, Amine Salt or Quaternary Ammonium Salt |
| 03/31/1992 | US5101013 Such as those obtained by enzymatic cleavage of proinsulin, ion exchanging |
| 03/31/1992 | US5100798 Method for the extraction of a vitamin-k-dependent carboxylase complex and the use thereof |
| 03/31/1992 | US5100788 Method of producing and isolating igg-binding protein a fusion peptides and a vector therefor |
| 03/31/1992 | US5100784 Microbiological synthesis, escherichia host |
| 03/31/1992 | US5100592 Heated rotary spreaders, two feed streams, melting and coating powders |
| 03/31/1992 | CA1298219C Homogeneous immune interferon fragment |
| 03/29/1992 | WO1992006186A1 Cloning cartridges and expression vectors in gram-negative bacteria |
| 03/29/1992 | WO1992006176A1 Surface expression libraries of randomized peptides |
| 03/29/1992 | WO1992006175A1 Method of improving the yield of heterologous proteins produced by streptomyces lividans |
| 03/29/1992 | WO1992006116A1 Hybrid growth factors |
| 03/29/1992 | WO1992006113A2 DERIVATIVES OF gp160 AND VACCINES BASED ON gp160 OR A DERIVATIVE THEREOF, CONTAINING AN ADJUVANT |
| 03/29/1992 | CA2092827A1 Derivatives of gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant |
| 03/29/1992 | CA2092803A1 Surface expression libraries of randomized peptides |
| 03/29/1992 | CA2090965A1 Method of improving the yield of heterologous proteins produced by streptomyces lividans |
| 03/29/1992 | CA2069746A1 Hybrid growth factors |
| 03/29/1992 | CA2052023A1 Expression vector construction utilizing viral sequences for selective expression of useful substances |
| 03/28/1992 | WO1992006199A2 Antibody inductor peptides inhibiting retroviruses of the hiv type and antibodies specific for said peptides |
| 03/28/1992 | CA2092546A1 Antibody inductor peptides inhibiting retrovirus of the hiv type and antibodies specific for said peptides |
| 03/28/1992 | CA2052283A1 Recombinant hybrid immunoglobulin molecules and method of use |
| 03/25/1992 | EP0476983A1 Vascular endothelial cell growth factor II |
| 03/25/1992 | EP0476287A2 Gene encoding a 30-kilodalton outer membrane protein of bordetella pertussis |
| 03/25/1992 | EP0476233A1 Human MK gene and protein sequence |
| 03/25/1992 | EP0476226A1 Monoclonal antibody against human IgE |
| 03/25/1992 | EP0476130A1 Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof |
| 03/25/1992 | EP0476022A1 Crystalline r-h-gm-csf and method for the preparation |
| 03/25/1992 | EP0476015A1 Recombinant alzheimer's amyloid protein |
| 03/25/1992 | EP0218713B1 High yield production of active factor ix |
| 03/25/1992 | CN1059761A Dna and its use |
| 03/25/1992 | CN1059729A Polypeptide compound and process for preparation thereof |
| 03/25/1992 | CA2051749A1 Cell adhesion molecule |
| 03/25/1992 | CA2050817A1 Hiv-neutralizing rat monoclonal antibodies against pb-1 |
| 03/24/1992 | US5099004 Antibodies such as monoclonal antibodies |
| 03/24/1992 | US5098887 Angiotensin converting enzyme inhibitor |
| 03/24/1992 | US5098829 Immunoadsorbents |
| 03/24/1992 | CA1297825C Antibiotics called "chloropolysporins b and c" a process for their preparation, and their therapeutic and veterinary use |
| 03/24/1992 | CA1297819C Hybridoma tumor cell lines and their monoclonal antibodies to theumatin |
| 03/24/1992 | CA1297818C Anti-urokinase monoclonal antibody, matrix bearing it, test method and biochemical test kits which use it |
| 03/24/1992 | CA1297817C Monoclonal antibody specific to a common determinant site of neutrophilsand eosinophils |
| 03/24/1992 | CA1297816C Platelet function inhibiting monoclonal antibody fragment |
| 03/24/1992 | CA1297815C Fibrinogen blocking monoclonal antibody |
| 03/24/1992 | CA1297814C Process for production of insulin-like growth factor i and plasmid for production thereof |
| 03/24/1992 | CA1297813C Process for production of insulin-like growth factor i |
| 03/22/1992 | CA2051829A1 Gene encoding a 30-kilodalton outer membrane protein of bordetella pertussis |
| 03/22/1992 | CA2051796A1 Vascular endothelial cell growth factor ii |
| 03/20/1992 | WO1992004911A1 Substantially pure interleukin-9 receptor and uses thereof |
| 03/19/1992 | WO1992005273A1 Gene therapy for cystic fibrosis |
| 03/19/1992 | WO1992004464A1 Monoclonal antibodies against tenascin |
| 03/19/1992 | WO1992004461A1 Genetically engineered coccidiosis vaccine |
| 03/19/1992 | WO1992004452A1 Transcription initiation regulating nucleotide sequence |
| 03/19/1992 | WO1992004448A2 Human mitochondrial nad(p)+-dependent malate enzyme |
| 03/19/1992 | WO1992004446A1 Cloning of chicken anaemia dna |
| 03/19/1992 | WO1992004445A1 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 03/19/1992 | WO1992004380A1 Specific binding agents |
| 03/19/1992 | WO1992004378A1 Recombinant agents affecting thrombosis |
| 03/19/1992 | WO1992004376A1 Novel chemotactic factor |
| 03/19/1992 | WO1992004050A1 Recombinant herpes simplex viruses vaccines and methods |
| 03/19/1992 | WO1992003918A1 Transgenic non-human animals capable of producing heterologous antibodies |
| 03/19/1992 | WO1992002612A3 Tissue plasminogen activator variants with decreased clearance |
| 03/19/1992 | WO1991018981A3 Neurotropic growth factors comprising a homeobox peptide |
| 03/19/1992 | CA2090410A1 Antithrombosis agents |
| 03/19/1992 | CA2090010A1 Nucleotidic sequence regulating the initiation of transcription |
| 03/18/1992 | WO1992005191A1 Fungicidally active compounds |
| 03/18/1992 | EP0475746A1 Human and murine interleukin-5 receptor |
| 03/18/1992 | EP0475719A2 Platelet derived growth regulating peptide |
| 03/18/1992 | EP0475656A2 The use of Bacillus thuringiensis microbes for controlling the lesser mealworm Alphitobius diaperinus |